Stock listing

ACET Stock Price, News, Filings & Events — Adicet Bio, Inc.

Selected listing: ACET · NASDAQ · USD · US

This page tracks Adicet Bio, Inc.'s ACET:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACET:NASDAQ. ACET:NASDAQ is the stock-level entry point for investors researching Adicet Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Adicet Bio, Inc. is a public biotechnology company based in the United States, trading under the ticker ACET. The company focuses on developing innovative therapies for cancer treatment. As of now, Adicet Bio has a market capitalization of approximately $75.9 million.

ACET:NASDAQUSDUSUpdated August 31, 2026
Adicet Bio, Inc. logo
Ticker
ACET:NASDAQ
Asset type
Stock
Market cap
$84.8M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Adicet Bio, Inc. ACET:NASDAQ stock context

This page tracks Adicet Bio, Inc.'s ACET:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACET:NASDAQ. ACET:NASDAQ is the stock-level entry point for investors researching Adicet Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Adicet Bio, Inc. is a public biotechnology company based in the United States, trading under the ticker ACET. The company focuses on developing innovative therapies for cancer treatment. As of now, Adicet Bio has a market capitalization of approximately $75.9 million.

Latest news from Adicet Bio, Inc.

All Adicet Bio, Inc. news →

Research Adicet Bio, Inc.

Alternate listings